Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.030
-0.030 (-2.83%)
At close: Dec 5, 2025, 4:00 PM EST
1.000
-0.030 (-2.91%)
After-hours: Dec 5, 2025, 7:16 PM EST
Lucid Diagnostics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Lucid Diagnostics stock have an average target of 3.88, with a low estimate of 2.00 and a high estimate of 8.00. The average target predicts an increase of 276.70% from the current stock price of 1.03.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Lucid Diagnostics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +191.26% | Nov 13, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.75 → $8 | Strong Buy | Maintains | $7.75 → $8 | +676.70% | Oct 6, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +142.72% | Sep 10, 2025 |
| BTIG | BTIG | Strong Buy Maintains $2 → $2.5 | Strong Buy | Maintains | $2 → $2.5 | +142.72% | Sep 5, 2025 |
| Needham | Needham | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +191.26% | Aug 13, 2025 |
Financial Forecast
Revenue This Year
4.88M
from 4.35M
Increased by 12.31%
Revenue Next Year
12.31M
from 4.88M
Increased by 152.14%
EPS This Year
-0.70
from -1.05
EPS Next Year
-0.35
from -0.70
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.9M | 15.3M | ||||
| Avg | 4.9M | 12.3M | ||||
| Low | 4.4M | 9.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 35.8% | 214.1% | ||||
| Avg | 12.3% | 152.1% | ||||
| Low | 1.5% | 97.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.55 | -0.27 | ||||
| Avg | -0.70 | -0.35 | ||||
| Low | -0.79 | -0.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.